PT-141, 10mg
$34.00
- Product Name: PT-141
- Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
- Molecular Formula: C₅₀H₆₈N₁₄O₁₀
- Molecular Weight: 1025.2 g/mol
- Research Only: Yes
- Form: Lyophilized Solid
- Storage: Keep refrigerated upon reconstitution
Some COAs may contain redactions of confidential or proprietary information. These redactions do not impact or obscure any analytical data, including compound identity, purity, or test results.
| Title | Range | Discount |
|---|---|---|
| 3-4 vials 5% off | 3 - 4 | 5% |
| Tiered Bulk Discount | 5 - 7 | 10% |
| Tiered Bulk Discount | 8 - 11 | 12% |
| Tiered Bulk Discount | 12 - 15 | 15% |
| Tiered Bulk Discount | 16 + | 20% |
PT-141 (also known as bremelanotide) is a melanocortin receptor agonist that has been studied in research settings for its interaction with central nervous system pathways. It is known to act on melanocortin receptors, particularly MC3R and MC4R, which are involved in neuroendocrine signaling and behavioral regulation.
Neurophysiological Mechanism
PT-141 has been investigated for its central (neurogenic) activity, distinguishing it from agents that act primarily on peripheral vascular pathways. Research suggests it may influence neurotransmitter systems involved in motivation and behavioral response, including dopaminergic and serotonergic signaling within limbic regions. These effects are being studied for their role in modulating sexual behavior and arousal-related pathways.
Male Sexual Function Research
PT-141 has been evaluated in clinical and preclinical studies involving male subjects, where it has been associated with measurable physiological responses under controlled conditions. Some research has explored its activity in populations with varying baseline function, including those who do not respond to other classes of compounds. Reported outcomes vary depending on study design, dosage, and population.
Female Sexual Function Research
PT-141 has also been studied in female populations and animal models for its potential effects on behavioral and physiological markers associated with sexual function. Preclinical studies have examined its influence on motivation-related behaviors, while limited clinical research has explored associations with self-reported measures of desire and arousal. These findings remain under investigation and are not yet fully established.
PT-141 is not approved by the U.S. Food and Drug Administration for human use. Its safety, efficacy, and pharmacological profile have not been established in approved FDA clinical trials. This compound is intended strictly for laboratory research purposes and is not for human or veterinary use.
Lyophilized Peptides
These peptides are freeze-dried, a process that not only extends shelf life but also preserves the purity and integrity of the peptides during storage.
Disclaimer: For Research Purposes only
This content is provided strictly for research purposes and does not constitute an endorsement or recommendation for the non-laboratory application or improper handling of peptides designed for research. The information, including discussions about specific peptides and their researched benefits, is presented for informational purposes only and must not be construed as health, clinical, or legal guidance, nor an encouragement for non-research use. Peptides described here are solely for use in structured scientific study by authorized individuals. We advise consulting with research experts, medical practitioners, or legal counsel prior to any decisions about obtaining or utilizing these peptides. The expectation of responsible, ethical utilization of this information for legitimate investigative and scholarly objectives is paramount. This notice is dynamic and governs all provided content on research peptides.
